Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark L Chiu

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Scientific Reports|June 1, 2017
Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent ModelsAran F Labrijn, Joyce I Meesters, Matthew Bunce, et al.
The Journal of Biological Chemistry|May 2, 2026
A Tri-specific EGFR/cMet/VEGF Antibody Demonstrates Potent Multi-Mechanistic Activity in Preclinical Triple-Negative Breast Cancer ModelsPu Pu, Ying Jin, Songling Zhang, et al.
The Journal of Biological Chemistry|April 11, 2021
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and METJoost Neijssen, Rosa M F Cardoso, Kristen M Chevalier, et al.
Protein Expression and Purification|January 6, 2009
Expression and purification of human TRPV1 in baculovirus-infected insect cells for structural studiesAlla Korepanova, Ana Pereda-Lopez, Larry R Solomon, et al.
Antibodies (Basel, Switzerland)|September 25, 2019
Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune FunctionalitySusan H Tam, Stephen G McCarthy, Anthony A Armstrong, et al.
Diabetes|November 1, 2016
Novel Monoclonal Antibody Is an Allosteric Insulin Receptor Antagonist That Induces Insulin ResistanceAnne M Cieniewicz, Thomas Kirchner, Simon A Hinke, et al.
Molecular Metabolism|February 18, 2018
Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibodySimon A Hinke, Anne M Cieniewicz, Thomas Kirchner, et al.
Cancer Research|May 25, 2016
A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor-Resistant Lung TumorsSheri L Moores, Mark L Chiu, Barbara S Bushey, et al.
Nature|March 4, 2011
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7Ingrid E Wertz, Saritha Kusam, Cynthia Lam, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Scientific Reports|June 1, 2017
Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent ModelsAran F Labrijn, Joyce I Meesters, Matthew Bunce, et al.
The Journal of Biological Chemistry|May 2, 2026
A Tri-specific EGFR/cMet/VEGF Antibody Demonstrates Potent Multi-Mechanistic Activity in Preclinical Triple-Negative Breast Cancer ModelsPu Pu, Ying Jin, Songling Zhang, et al.
The Journal of Biological Chemistry|April 11, 2021
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and METJoost Neijssen, Rosa M F Cardoso, Kristen M Chevalier, et al.
Protein Expression and Purification|January 6, 2009
Expression and purification of human TRPV1 in baculovirus-infected insect cells for structural studiesAlla Korepanova, Ana Pereda-Lopez, Larry R Solomon, et al.
Antibodies (Basel, Switzerland)|September 25, 2019
Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune FunctionalitySusan H Tam, Stephen G McCarthy, Anthony A Armstrong, et al.
Diabetes|November 1, 2016
Novel Monoclonal Antibody Is an Allosteric Insulin Receptor Antagonist That Induces Insulin ResistanceAnne M Cieniewicz, Thomas Kirchner, Simon A Hinke, et al.
Molecular Metabolism|February 18, 2018
Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibodySimon A Hinke, Anne M Cieniewicz, Thomas Kirchner, et al.
Cancer Research|May 25, 2016
A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor-Resistant Lung TumorsSheri L Moores, Mark L Chiu, Barbara S Bushey, et al.
Nature|March 4, 2011
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7Ingrid E Wertz, Saritha Kusam, Cynthia Lam, et al.
Pageof 5